Commission Implementing Regulation (EU) 2025/2154 of 17 October 2025 laying down good manufacturing practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council
Article 3Starting point for the manufacture of active substances
In force · version of Nov 16, 2025
1.The starting point at which the manufacture of an active substance starts shall be determined in accordance with the Annex to this Regulation. The reasons for the implemented approach shall be documented.
2.From the point determined in accordance with paragraph 1, the requirements set out in this Regulation shall apply.